My ePortfolio Register   
Filter results by:

Showing: All

Special Issue: Next-generation sequencing in NSCLC and melanoma patients: a cost and budget impact analysis

Abstract | Full Article | PDF Published: 28 Oct 2016 / DOI: 10.3332/ecancer.2016.684

Special Issue: Innovations that reach the patient: early health technology assessment and improving the chances of coverage and implementation

Abstract | Full Article | PDF Published: 28 Oct 2016 / DOI: 10.3332/ecancer.2016.683

Research: Comparison between standard and reduced volume radiotherapy in bladder preservation trimodality protocol for muscle-invasive bladder cancer patients

Abstract | Full Article | PDF Published: 26 Oct 2016 / DOI: 10.3332/ecancer.2016.682

Policy: Phosphoethanolamine and the danger of unproven drugs

Abstract | Full Article | PDF | Portuguese Published: 17 Oct 2016 / DOI: 10.3332/ecancer.2016.681

Clinical Study: Repurposing Drugs in Oncology (ReDO)—Propranolol as an anti-cancer agent

Abstract | Full Article | PDF Published: 12 Oct 2016 / DOI: 10.3332/ecancer.2016.680

Research: Prognostic and predictive implications of Sokal, Euro and EUTOS scores in chronic myeloid leukaemia in the imatinib era—experience from a tertiary oncology centre in Southern India

Abstract | Full Article | PDF Published: 06 Oct 2016 / DOI: 10.3332/ecancer.2016.679

Case Report: The first case of benign multicystic mesothelioma presenting as a splenic mass

Abstract | Full Article | PDF Published: 04 Oct 2016 / DOI: 10.3332/ecancer.2016.678

Research: VERO® radiotherapy for low burden cancer: 789 patients with 957 lesions

Abstract | Full Article | PDF Published: 29 Sep 2016 / DOI: 10.3332/ecancer.2016.677

Clinical Study: Conditional survival of metastatic renal cell carcinoma patients treated with high-dose interleukin-2

Abstract | Full Article | PDF Published: 29 Sep 2016 / DOI: 10.3332/ecancer.2016.676

Research: The analytical validation of the Oncotype DX Recurrence Score assay

Abstract | Full Article | PDF Published: 26 Sep 2016 / DOI: 10.3332/ecancer.2016.675



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence